Treatment of Locally Advanced Melanoma by Isolated Limb Infusion with Cytotoxic Drugs
Journal of Skin Cancer · 2011
DOI: 10.1155/2011/106573 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Skin Cancer, 2011. Verfasst von Hidde M Kroon. Beteiligte Einrichtung: Melanoma Institute Australia, Royal Prince Alfred Hospital, University of Sydney, Missenden Road Camperdown, NSW 2050, Australia. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0).
Abstract (Originalsprache)
Since its introduction in the late 1950s, isolated limb perfusion (ILP) has been the preferred treatment option for locally advanced melanoma and sarcoma confined to a limb. This treatment results in high response rates with a satisfying duration of response in both tumor types. A drawback of ILP, however, is the invasive and complex character of the procedure. Isolated limb infusion (ILI) has been designed in the early 1990s as a minimally invasive alternative to ILP. Results of this simple procedure, reported by various centers around the world, show comparable response rates for melanoma and sarcoma when compared to ILP. Due to its minimally invasive character, ILI may replace ILP in the future as the preferred treatment for these locally advanced limb tumors.
Autor:innen und Institutionen
- Melanoma Institute Australia, Royal Prince Alfred Hospital, University of Sydney, Missenden Road Camperdown, NSW 2050, Australia.
Zitieren
APA
Kroon, H. M. (2011). Treatment of Locally Advanced Melanoma by Isolated Limb Infusion with Cytotoxic Drugs. Journal of Skin Cancer. https://doi.org/10.1155/2011/106573
Vancouver
Kroon HM. Treatment of Locally Advanced Melanoma by Isolated Limb Infusion with Cytotoxic Drugs. Journal of Skin Cancer. 2011. doi:10.1155/2011/106573
BibTeX
@article{Kroon2011,
author = {Kroon, Hidde M},
title = {Treatment of Locally Advanced Melanoma by Isolated Limb Infusion with Cytotoxic Drugs},
journal = {Journal of Skin Cancer},
year = {2011},
doi = {10.1155/2011/106573}
}
EUVIMED